Kymera Therapeutics, Inc. - KYMR
About Gravity Analytica
Recent News
- 09.17.2025 - Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses
- 09.17.2025 - Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses
- 09.16.2025 - Brian Abrahams
- 09.16.2025 - Felix J. Baker, PhD
- 09.15.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
- 09.15.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
- 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
- 09.04.2025 - Wells Fargo 2025 Healthcare Conference
- 09.04.2025 - Wells Fargo 2025 Healthcare Conference
Recent Filings
- 09.17.2025 - 144 Report of proposed sale of securities
- 09.17.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.16.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.16.2025 - 144 Report of proposed sale of securities
- 09.03.2025 - EX-99.1 EX-99.1
- 09.03.2025 - 8-K Current report